← Back to Clinical Trials
Recruiting NCT02060565
Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease
Trial Parameters
Condition Chronic Liver Disease
Sponsor Association HGE CHU Bordeaux Sud
Study Type OBSERVATIONAL
Phase N/A
Enrollment 10,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2014-02
Completion 2030-01
Brief Summary
The aim of this retrospective and prospective study is to evaluate the 20-year prognosis value of non-invasive methods for the diagnosis of chronic liver disease for predicting survival and complications of cirrhosis.
Eligibility Criteria
Inclusion Criteria: * chronic hepatitis C * chronic hepatitis B * alcohol liver disease * non alcoholic liver disease Exclusion Criteria: * ascitis